Kodak has agreed to produce pharmaceutical ingredients in the US thus reducing dependency on other countries by strengthening domestic supply chains.
The US International Development Finance Corp said it would sign a letter of interest to provide the loan to Kodak.
News of the deal sent Kodak shares on whirlwind high trading at $8.80 after closing at $2.62 in the previous session.
Although Kodak has been tapped by the US government to manufacture pharmaceutical ingredients, the company is more well-known for its cameras and imaging business.
The Trump administration has been looking to bolster the ability to produce drugs and their raw materials in the United States.
The decision came after the Covid-19 pandemic exposed the industry's dependence on China and India for its supply chain.
"This is the beginning of American independence from our pharmaceutical dependence on foreign countries," White House trade adviser Peter Navarro said in an interview with Fox Business network.
In May, the administration awarded a contract worth up to $812 million for a new US company to manufacture drugs and drug ingredients in the country.